Status:
UNKNOWN
Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.
Lead Sponsor:
V.K.V. American Hospital, Istanbul
Conditions:
Polycystic Ovarian Syndrome
Eligibility:
FEMALE
20-35 years
Brief Summary
The investigators aim to compare the levels of bone morphogenetic protein-4 and -7 (BMP-4 and 7) in blood, follicular fluid and ovarian organ culture supernatant obtained from healthy subjects and pol...
Detailed Description
Female patients at ages 20-35 diagnosed with polycystic ovarian syndrome and age-matched healthy control subjects will be enrolled in this study. Blood samples will be obtained at early follicular ph...
Eligibility Criteria
Inclusion
- Healthy subjects and PCOS patients at ages 20-35 will be recruited for the study.
Exclusion
- Those with any metabolic or endocrine problems other than PCOS will be excluded from the study.
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01162447
Start Date
February 1 2010
End Date
February 1 2011
Last Update
July 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American Hospital Women's Health Center
Istanbul, Turkey (Türkiye), 34365